術中神経モニタリングの市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2023～2030年

術中神経モニタリング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の術中神経モニタリング市場規模は、2023年から2030年にかけてCAGR 4.9％を記録し、2030年には46億5,000万米ドルに達すると予測されています。

この成長は、技術の進歩、デバイスの安全性に関する意識の高まり、老人人口の増加に起因しています。COVID-19のアウトブレイクは市場に二重の影響を与えると予想されます。2020年3月、米国外科学会（ACS）は、米国でCOVID-19の症例が急速に増加したため、選択的手術の縮小、延期、中止を提案する声明を発表したが、これが成長の妨げになると予想されます。

さらに、エルゼビア誌に掲載された調査（国際出血性脳卒中協会；2021年1月）によると、入院したCOVID-19患者の最大36％が神経症状を示す可能性があり、虚血性・出血性梗塞に関連する症例が複数あっています。さらに、2021年6月にNeurology Online Journalに掲載された別の最近の調査では、COVID-19ウイルスが新たな神経疾患の発症に関与している可能性が示唆されています。新疾患の増加により、院内死亡のリスクが高くなり、退院率が低下しています。これらの特徴は、予測期間中に有利な成長をもたらすと予想されます。

さらに、脳神経外科手術の件数と手ごろな価格の増加、手術における患者の安全性の重視の高まりにより、同市場は成長が見込まれています。術中神経モニタリング（IONM）は、再手術の回数を減らし、術後合併症や後遺症の発生を減らすことができるため、病院は幅広い手術に採用しています。

術中神経モニタリング市場レポートハイライト

• タイプ別では、2022年に54.4%の最大シェアを占めたのはインソースセグメントでした。これは、IONMの利点について患者だけでなく医師の間でも認識が高まっており、その結果、病院が複雑な手術中にIONMを利用するようになったためと考えられます。これが、この市場でIONMが優位を占める主な理由です。
• 地域別では、北米が2022年に49.3%の最大シェアを占めました。有利な償還シナリオと技術の進歩がこの優位性の理由です。
• アジア太平洋は、予測期間中に5.46%という最も速いCAGRを記録すると予想されています。高齢者人口の増加、手術件数の増加、ヘルスケアへの支出増がこの成長の要因と考えられます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 術中神経モニタリング市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
• 術中神経モニタリング市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 術中神経モニタリング市場：タイプ別推定・動向分析

• 術中神経モニタリング市場：重要なポイント
• 術中神経モニタリング市場：タイプの動きと市場シェア分析、2022年と2030年
• インソース
• アウトソース

第5章 術中神経モニタリング市場：地域別推定・動向分析

• 地域別の見通し
• 地域別の術中神経モニタリング市場：重要なポイント
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • ノルウェー
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第6章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 市場参入企業の分類
  • Natus Medical Incorporated
  • Accurate Monitoring
  • Neuromonitoring Technologies
  • Medtronic
  • NuVasive, Inc.
  • SpecialtyCare

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 3 North America intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
• Table 4 U.S. intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 5 Canada intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 6 Europe intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 7 Europe intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
• Table 8 Germany intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 9 UK intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 10 France intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 11 Italy intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 12 Spain intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 13 Sweden intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 14 Norway intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 15 Denmark intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 16 Asia Pacific intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 17 Asia Pacific intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
• Table 18 Japan intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 19 China intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 20 India intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 21 Australia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 22 Thailand intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 23 South Korea intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 24 Latin America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 25 Latin America intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
• Table 26 Brazil intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 27 Mexico intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 28 Argentina intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 29 Middle East and Africa intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 30 Middle East and Africa intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
• Table 31 South Africa intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 32 Saudi Arabia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 33 UAE intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 34 Kuwait intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 QFD modeling for market share assessment
• Fig. 6 Market formulation & validation
• Fig. 7 Intraoperative neuromonitoring: Market outlook
• Fig. 8 Intraoperative neuromonitoring: Competitive insights
• Fig. 9 Parent market outlook
• Fig. 10 Related/ancillary market outlook
• Fig. 11 Penetration and growth prospect mapping
• Fig. 12 Industry value chain analysis
• Fig. 13 Intraoperative neuromonitoring market driver impact
• Fig. 14 Intraoperative neuromonitoring market restraint impact
• Fig. 15 Intraoperative neuromonitoring market strategic initiatives analysis
• Fig. 16 Intraoperative neuromonitoring market: Type movement analysis
• Fig. 17 Intraoperative neuromonitoring market: Type outlook and key takeaways
• Fig. 18 Insourced market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Outsourced market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Global intraoperative neuromonitoring market: Regional movement analysis
• Fig. 21 Global intraoperative neuromonitoring market: Regional outlook and key takeaways
• Fig. 22 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Intraoperative Neuromonitoring Market Growth & Trends:

The global intraoperative neuromonitoring market size is expected to reach USD 4.65 billion by 2030, registering a CAGR of 4.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. This growth can be attributed to technological advancements, increasing awareness regarding the safety of the devices, and the growing geriatric population. The COVID-19 outbreak is expected to have a dual impact on the market. In March 2020, the American College of Surgeons (ACS) published a proposal to reduce, postpone, or cancel elective surgeries as COVID-19 cases grew quickly in the U.S., which is expected to hamper growth.

Moreover, according to a research study published in Elsevier journal (International Hemorrhagic Stroke Association; Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms, and there were several cases related to ischemic & hemorrhagic infarction. In addition, another recent research study published in Neurology Online Journal in June 2021 proposed that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases. Owing to the growth of new diseases, there is a higher risk of in-hospital mortality and a low discharge rate. These characteristics are expected to result in lucrative growth over the forecast period.

Furthermore, the market is expected to witness growth due to the increasing number & affordability of neurosurgeries and the growing emphasis on patient safety in surgeries. Hospitals are adopting Intraoperative Neuromonitoring (IONM) in a wide spectrum of surgeries, as it reduces the number of revision surgeries and results in fewer postoperative complications & cases of permanent impairment.

Intraoperative Neuromonitoring Market Report Highlights:

• By type, the insourced segment accounted for the largest share of 54.4% in 2022. This can be attributed to growing awareness among physicians as well as patients about the benefits of IONM, which results in the hospitals utilizing IONM during complex procedures. This is a key reason for the dominance of insourced IONM in the market
• By region, North America accounted for the largest share of 49.3% in 2022. Favorable reimbursement scenarios along with technological advancements can be attributed to this dominance
• Asia Pacific is expected to witness the fastest CAGR of 5.46% over the forecast period. The growing geriatric population, increasing number of surgeries, and rising expenditure on healthcare can be attributed to this growth

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Intraoperative Neuromonitoring Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Intraoperative Neuromonitoring Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Intraoperative Neuromonitoring Market: Type Estimates & Trend Analysis

• 4.1. Intraoperative Neuromonitoring Market: Key Takeaways
• 4.2. Intraoperative Neuromonitoring Market: Type Movement & Market Share Analysis, 2022 & 2030
• 4.3. Insourced
  • 4.3.1. Insourced market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Outsourced
  • 4.4.1. Outsourced market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Intraoperative Neuromonitoring Market: Regional Estimates & Trend Analysis

• 5.1. Regional Outlook
• 5.2. Intraoperative Neuromonitoring Market by Region: Key Takeaways
• 5.3. North America
  • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.3.2. U.S.
    • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.3.3. Canada
    • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.4. Europe
  • 5.4.1. UK
    • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4.2. Germany
    • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4.3. France
    • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4.4. Italy
    • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4.5. Spain
    • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4.6. Sweden
    • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4.7. Norway
    • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4.8. Denmark
    • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Japan
    • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5.2. China
    • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5.3. India
    • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5.4. Australia
    • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5.5. Thailand
    • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5.6. South Korea
    • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.6. Latin America
  • 5.6.1. Brazil
    • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6.2. Mexico
    • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6.3. Argentina
    • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.7. MEA
  • 5.7.1. South Africa
    • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7.2. Saudi Arabia
    • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7.3. UAE
    • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7.4. Kuwait
    • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Market Participant Categorization
  • 6.2.1. Natus Medical Incorporated
    • 6.2.1.1. Company overview
    • 6.2.1.2. Financial performance
    • 6.2.1.3. Product benchmarking
    • 6.2.1.4. Strategic initiatives
  • 6.2.2. Accurate Monitoring
    • 6.2.2.1. Company overview
    • 6.2.2.2. Financial performance
    • 6.2.2.3. Product benchmarking
    • 6.2.2.4. Strategic initiatives
  • 6.2.3. Neuromonitoring Technologies
    • 6.2.3.1. Company overview
    • 6.2.3.2. Financial performance
    • 6.2.3.3. Product benchmarking
    • 6.2.3.4. Strategic initiatives
  • 6.2.4. Medtronic
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. NuVasive, Inc.
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. SpecialtyCare
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives